What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in Q2 2017?

138 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 312,579,912
Total 13F shares: 174,164,391
Share change: +12,461,173
Total reported value: $1,753,807,994
Put/Call ratio: 36%
Price per share: $10.07
Number of holders: 138
Value change: +$127,263,729
Number of buys: 68
Number of sells: 62

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6.6%	20,732,355	$147,822,000	—	31 Mar 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	5.5%	17,296,672	$123,325,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	3.8%	11,967,596	$85,330,000	—	31 Mar 2017	13F
Redmile Group, LLC	13F	Company	3.6%	11,375,852	$81,110,000	—	31 Mar 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	2.9%	9,035,667	$64,424,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	2.8%	8,687,760	$61,944,000	—	31 Mar 2017	13F
Palo Alto Investors LP	13F	Company	2.5%	7,882,988	$56,206,000	—	31 Mar 2017	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	2.3%	7,136,697	$50,883,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	2%	6,128,481	$43,696,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	1.8%	5,766,929	$41,118,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.7%	5,341,132	$38,083,000	—	31 Mar 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.6%	4,958,719	$35,356,000	—	31 Mar 2017	13F
Avoro Capital Advisors LLC	13F	Company	1.6%	4,847,577	$34,563,000	—	31 Mar 2017	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.4%	4,311,696	$30,742,000	—	31 Mar 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	1.1%	3,581,938	$25,539,000	—	31 Mar 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.96%	3,000,500	$21,394,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.91%	2,841,830	$20,262,000	—	31 Mar 2017	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.83%	2,600,014	$18,538,000	—	31 Mar 2017	13F
AXA S.A.	13F	Company	0.69%	2,168,358	$15,460,000	—	31 Mar 2017	13F
Artal Group S.A.	13F	Company	0.61%	1,900,000	$13,547,000	—	31 Mar 2017	13F
FRANKLIN RESOURCES INC	13F	Company	0.6%	1,886,300	$13,449,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.54%	1,685,441	$12,017,000	—	31 Mar 2017	13F
GCM Grosvenor L.P.	13F	Company	0.52%	1,630,605	$11,626,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.47%	1,465,914	$10,452,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.45%	1,393,057	$9,932,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	1,167,356	$8,323,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.34%	1,050,718	$7,488,000	—	31 Mar 2017	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.33%	1,030,300	$7,346,000	—	31 Mar 2017	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.31%	983,981	$7,016,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.3%	926,483	$6,605,000	—	31 Mar 2017	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.26%	813,700	$5,801,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.25%	777,146	$5,541,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	0.25%	772,857	$5,510,000	—	31 Mar 2017	13F
Rock Springs Capital Management LP	13F	Company	0.24%	757,500	$5,401,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.23%	726,900	$5,183,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.22%	672,418	$4,794,000	—	31 Mar 2017	13F
Asymmetry Capital Management, L.P.	13F	Company	0.2%	634,865	$4,527,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	562,951	$4,014,000	—	31 Mar 2017	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.16%	500,000	$3,565,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	435,615	$3,106,000	—	31 Mar 2017	13F
Tekla Capital Management LLC	13F	Company	0.13%	418,730	$2,986,000	—	31 Mar 2017	13F
GW&K Investment Management, LLC	13F	Company	0.13%	397,025	$2,831,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.12%	360,148	$2,568,000	—	31 Mar 2017	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	313,869	$2,238,000	—	31 Mar 2017	13F
Hudson Bay Capital Management LP	13F	Company	0.1%	300,000	$2,139,000	—	31 Mar 2017	13F
CREDIT SUISSE AG/	13F	Company	0.09%	293,767	$2,095,000	—	31 Mar 2017	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.09%	285,913	$2,039,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	280,638	$2,001,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.08%	253,499	$1,807,000	—	31 Mar 2017	13F
Endurant Capital Management LP	13F	Company	0.07%	223,300	$1,592,000	—	31 Mar 2017	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2017

As of 30 Jun 2017, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 174,164,391 shares. The largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, Palo Alto Investors, LLC, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 138 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

128

Q2 2017 holders

138

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.